Art Of The Brain : Yesterday, Today and Tomorrow. Giving new hope for brain cancer survival.

Next Event

Corporate Partners

Whats New: Art of the Brain

•	Art of the Brain 11th Annual Gala: “The Gleeful Art of Sportsmanship”
	10/3/2010 8:00 AM PST [ArtOfTheBrain.org]
•	Judi Kaufman: Brain cancer survivor founds nonprofit Art of the Brain to help other patients
	10/20/2008 8:00 AM PST [Los Angeles Times]
•	Local Entrepreneur Judi Kaufman Fights Back Against Brain Cancer
	10/12/2008 8:00 AM PST [Beverly Hills Courier]
•	Cancer survivor brings art, courage to other patients
	9/17/2008 8:00 AM PST [The Jewish Journal]
•	Art of the Brain 8th Annual Gala - An Inspirational Global Pursuit for the Cure
	4/1/2008 8:00 AM PST [BreakthroughsMag]

Brain Cancer Research In The News

•	Brain tumor awareness month
	Mon, 20 May 2013 18:03:07 GMT (Q13 FOX)

•	Brain Tumor Victim Lives On Through Charity Event
	Mon, 20 May 2013 22:04:56 GMT (NBC4i.com)

•	Brain cancer survivors participate in marathon
	Sun, 19 May 2013 03:27:57 GMT (KVUE)

•	Milltown family continues to raise awareness about brain tumors
	Sat, 18 May 2013 09:53:05 GMT (MyCentralJersey.com)

•	Figure skating club alters performance to feature skater with brain tumor
	Sun, 19 May 2013 03:59:59 GMT (fox13now.com)

•	Foreigner singer Lou Gramm explains how drugs and a brain tumor nearly killed ...
	Thu, 16 May 2013 12:30:22 GMT (Fox News)

•	Thousands Show Support for Hastings Student Battling Brain Tumor
	Mon, 20 May 2013 02:29:43 GMT (1011 Home)

•	Local fundraiser helps fuel brain tumor research
	Sun, 19 May 2013 14:22:54 GMT (WXXA)

•	Playing Through the Pain
	Mon, 20 May 2013 14:08:55 GMT (of Two Brain Tumors)

•	Health department conducting statewide scan for brain tumors
	Fri, 17 May 2013 03:57:12 GMT (ksl.com)

Recent Initiatives funded in part by Art of the Brain


	It is time to include patients with brain tumors in phase I trials in oncology. J Clin Oncol.		Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol.

	Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma. Neuro Oncol.		Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol.

	Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study. J Clin Oncol.		Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol.

	Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab. Magn Reson Med.		Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept. Clin Cancer Res.

	International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol.		Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol.

	AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme. Adv Ther.		Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.Portions Copyright (Search, Chart, Content Publishing Tools) 1998-2013 SiliconMED

[Content Published:5/21/2013 12:14:53 PM PST]